CAULI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 202.363
NA - Nord America 12.359
AS - Asia 4.854
SA - Sud America 1.047
AF - Africa 125
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 3
Totale 220.794
Nazione #
IT - Italia 198.279
US - Stati Uniti d'America 12.175
SG - Singapore 1.863
CN - Cina 1.827
NL - Olanda 1.135
BR - Brasile 854
UA - Ucraina 747
SE - Svezia 656
DE - Germania 503
VN - Vietnam 372
FI - Finlandia 327
GB - Regno Unito 254
KR - Corea 145
FR - Francia 124
CA - Canada 118
HK - Hong Kong 107
IN - India 99
AR - Argentina 77
JP - Giappone 75
BD - Bangladesh 59
ES - Italia 55
TR - Turchia 49
AT - Austria 44
ID - Indonesia 43
PL - Polonia 42
AU - Australia 38
IQ - Iraq 38
MX - Messico 34
RU - Federazione Russa 34
EC - Ecuador 33
IR - Iran 32
ZA - Sudafrica 31
BE - Belgio 27
CZ - Repubblica Ceca 22
EG - Egitto 21
IE - Irlanda 21
CO - Colombia 18
MA - Marocco 17
IL - Israele 16
UZ - Uzbekistan 16
JO - Giordania 15
TN - Tunisia 15
VE - Venezuela 15
LT - Lituania 14
CL - Cile 13
PY - Paraguay 13
GR - Grecia 10
PE - Perù 10
SA - Arabia Saudita 10
TW - Taiwan 10
CH - Svizzera 9
KE - Kenya 9
PK - Pakistan 9
DK - Danimarca 8
DZ - Algeria 8
RO - Romania 8
AZ - Azerbaigian 7
KG - Kirghizistan 7
PH - Filippine 7
PT - Portogallo 7
BG - Bulgaria 6
BO - Bolivia 6
NP - Nepal 6
SN - Senegal 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
RS - Serbia 5
SI - Slovenia 5
CR - Costa Rica 4
ET - Etiopia 4
GH - Ghana 4
HN - Honduras 4
HR - Croazia 4
LB - Libano 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BJ - Benin 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
KH - Cambogia 3
MD - Moldavia 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
EU - Europa 2
GE - Georgia 2
JM - Giamaica 2
KZ - Kazakistan 2
LC - Santa Lucia 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
Totale 220.771
Città #
Cagliari 190.988
Uta 6.474
Dallas 1.390
Fairfield 1.219
Amsterdam 1.108
Woodbridge 1.034
Ashburn 976
Singapore 826
Boardman 682
Houston 661
Chandler 643
Wilmington 523
Ann Arbor 479
Seattle 443
Nyköping 405
Cambridge 393
Jacksonville 390
Beijing 366
Dearborn 237
Los Angeles 207
Munich 191
Hefei 185
Helsinki 164
Shanghai 160
Santa Clara 157
Boston 156
Nanjing 141
Seoul 129
Buffalo 128
Dong Ket 118
The Dalles 102
Ho Chi Minh City 99
Hong Kong 97
San Diego 92
New York 87
Rome 82
São Paulo 73
Milan 68
Redwood City 62
Chicago 60
Toronto 58
Shenyang 52
London 50
Guangzhou 49
Hanoi 47
Nanchang 45
Redondo Beach 45
Tokyo 43
Nuremberg 41
Hebei 37
Phoenix 37
Tianjin 33
Mountain View 29
Belo Horizonte 28
Jiaxing 27
Brooklyn 26
Rio de Janeiro 25
Sassari 25
Changsha 24
Auburn Hills 21
Falls Church 21
Frankfurt am Main 21
Warsaw 21
Johannesburg 20
Montreal 20
Stockholm 20
Turku 20
Baghdad 19
Brussels 19
Dublin 18
Guayaquil 18
Lappeenranta 18
Norwalk 18
Orange 18
Salt Lake City 18
San Francisco 18
Washington 18
Denver 17
Vienna 17
Düsseldorf 16
Elk Grove Village 16
Pune 16
San Mateo 16
Amman 15
Atlanta 15
Dhaka 15
Mexico City 15
Tashkent 15
Jinan 14
Lauterbourg 14
Ningbo 14
Columbus 13
Curitiba 13
Kunming 13
Verona 13
Zhengzhou 13
Brasília 12
Hyderabad 12
Madrid 12
Mumbai 12
Totale 213.190
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.708
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.129
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.026
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.004
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 2.982
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.875
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.788
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.774
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.763
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 2.601
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.591
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.573
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.324
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.308
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.303
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 2.261
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.258
null 2.245
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.224
Polymyalgia rheumatica: an autoinflammatory disorder? 2.216
Spa therapy induces clinical improvement and protein changes in patients with chronic back pain 2.208
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.160
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.160
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 2.127
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.127
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus 2.102
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 2.100
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.071
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.046
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 1.995
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 1.959
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.925
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.925
Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia 1.920
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.900
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.896
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.893
null 1.791
Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation 1.785
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.754
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.663
Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia : Implications for disease pathogensis 1.649
ENDODONTIC RETREATMENT AS AN ALTERNATIVE TO SURGICAL THERAPY IN PATIENTS TREATED WITH BIPHOSPHONATES: A CASE REPORT 1.605
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.593
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 1.591
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.566
null 1.562
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.550
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.511
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology 1.449
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.437
null 1.431
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.419
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.412
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.344
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients 1.280
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 1.238
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.233
Circulating CD8+CD28(null) T cytotoxic cells in polymyositis - a possible biomarker? Comment on the article by Pandya et al. 1.206
Targeted Therapies in Axial Psoriatic Arthritis 1.116
null 1.111
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) 1.107
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 1.094
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.091
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis Reply 1.070
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.032
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis 1.006
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.004
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 993
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis 984
Updated guidelines for the management of axial disease in psoriatic arthritis 982
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 978
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 974
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 956
Proceedings of the GRAPPA 2016 retreat 944
Corrigendum to: Exercise Improves the Impact of Chronic Pain in Older Adults: Results of an RCT 940
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 905
null 902
Psoriatic disease: Update on traditional disease-modifying antirheumatic drugs 895
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 893
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 890
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 874
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 872
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? 864
Whole-body MRI in rheumatology: Major advances and future perspectives 853
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 849
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 834
null 831
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 826
Familial chilblain and late contractural arachnodactyly: A novel association? 824
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 816
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 804
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 794
Exercise Improves the Impact of Chronic Pain in Older Adults: Results of an RCT 793
Asymmetric dimethylarginine: A key player in the pathophysiology of endothelial dysfunction, vascular inflammation and atherosclerosis in rheumatoid arthritis? 786
Genetics of psoriasis and psoriatic arthritis 784
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 779
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern 777
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 776
Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity 764
Totale 164.903
Categoria #
all - tutte 301.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 301.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116.537 0 0 0 0 0 4.829 3.977 2.068 816 1.633 1.733 1.481
2021/202211.072 922 840 574 479 785 906 587 533 1.239 989 1.702 1.516
2022/202316.533 1.647 1.953 1.536 1.338 1.554 1.729 922 1.556 1.055 1.132 1.323 788
2023/202429.092 1.222 1.181 1.002 1.790 2.611 3.741 3.782 6.325 1.202 1.516 2.559 2.161
2024/202552.632 12.511 11.951 8.614 5.747 2.949 2.973 4.173 324 567 1.589 540 694
2025/20266.632 930 834 2.046 1.449 1.221 152 0 0 0 0 0 0
Totale 221.761